 CHESTER, N.Y.--BUSINESS WIRE--Repro Med Systems, Inc. dba KORU Medical Systems NASDAQ: KRMD KORU Medical or the Company today announced financial results for the third quarter ended September 30, 2020 Q3 2020. Q3 2020 Overview The strength and resiliency of our core business, which provides our Freedom Integrated Infusion System to individuals with Primary Immune Deficiency Disease and Chronic Inflammatory Demyelinating Polyneuropathy, is helping us navigate the challenges of the 